Syndax Pharmaceuticals, Inc. — Balance Sheet Charts
46 snapshots of history · ending 2025-12-31 · SEC EDGAR
QuarterlyAnnual
Total Assets↓-26.9% -$195M
$530M
Current Assets↓-12.4% -$75M
$528M
Cash & Equivalents↓-12.4% -$19M
$135M
ST Investments↓-38.1% -$160M
$259M
Receivables↑+399.8% +$30M
$38M
Inventory↑+8849.2% +$32M
$33M
Net PPE
$181K
Total Liabilities↑+6.5% +$28M
$465M
Current Liabilities↑+16.0% +$17M
$120M
Stockholders Equity↓-77.6% -$223M
$65M
Retained Earnings↓-23.4% -$285M
$-1.51B